{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:51:56Z","timestamp":1790538716052,"version":"4.1.0"},"reference-count":46,"publisher":"American Chemical Society (ACS)","issue":"6","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010771","name":"Loo och Hans Ostermans Stiftelse f\u00f6r Medicinsk Forskning","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100010771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["4-1616"],"award-info":[{"award-number":["4-1616"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2024-02600"],"award-info":[{"award-number":["2024-02600"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"Dr. Margaretha Nilsson's Foundation","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"MRC TransNAT","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Effective extrahepatic activity of therapeutic oligonucleotides remains an unresolved and significant problem in the development of new genetic medicines. Targeted delivery to the heart is of particular interest due to the unmet need to treat an increasing health burden of cardiovascular diseases and the identification of potential genetic therapeutic targets. Drawing inspiration from literature, we investigate the potential of tannic acid (TA) modifications to improve the activity of a model siRNA sequence in the heart. We developed the synthesis of a series of conjugates containing 1\u20133 (TA) units to study how molecularly defined numbers of TA ligands influence activity. While we observe significant knockdown of the siRNA target gene in the liver, we did not in the heart, suggesting that although TA ligands confer improved function of siRNA in the liver, extrahepatic activity was not enhanced. In addition, hetero-bifunctional siRNA conjugates containing both TA and albumin binding motifs were designed and their synergistic effects explored. Similarly, in vivo data suggests that TA ligands do not increase cardiac activity of siRNA in this context; however, we can conclude that both C16 and AlbuTag ligands do significantly improve siRNA activity in the heart. We believe this work provides important bioconjugation insight for polyphenolic molecules, like tannic acid, as well as the synthesis of hetero-bifunctional siRNA conjugates generally. Moreover, our findings will inform the design of novel targeting ligands and nanomaterials, especially for molecules that may possess emergent properties when present in high multiplicity compared to their monomeric forms.<\/jats:p>","DOI":"10.1021\/acs.bioconjchem.6c00122","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:59:01Z","timestamp":1779897541000},"page":"1121-1128","source":"Crossref","is-referenced-by-count":1,"title":["Investigating\nthe\n                    <i>In Vivo<\/i>\n                    Performance\nof Tannic Acid-Modified siRNA in the Heart and Liver"],"prefix":"10.1021","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9647-6411","authenticated-orcid":true,"given":"O. G.","family":"Hayes","sequence":"first","affiliation":[{"name":"Karolinska Institutet , , ,","place":["Huddinge, Stockholm, Sweden, 14152"]},{"name":"Karolinska University Hospital , , ,","place":["Stockholm, Sweden, 14186"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ra\u0308dler","sequence":"additional","affiliation":[{"name":"Karolinska Institutet , , ,","place":["Huddinge, Stockholm, Sweden, 14152"]},{"name":"Karolinska University Hospital , , ,","place":["Stockholm, Sweden, 14186"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Filipiak","sequence":"additional","affiliation":[{"name":"Karolinska Institutet , , ,","place":["Huddinge, Stockholm, Sweden, 14152"]},{"name":"Karolinska University Hospital , , ,","place":["Stockholm, Sweden, 14186"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Czapik","sequence":"additional","affiliation":[{"name":"Karolinska Institutet , , ,","place":["Huddinge, Stockholm, Sweden, 14152"]},{"name":"Karolinska University Hospital , , ,","place":["Stockholm, Sweden, 14186"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Huang","sequence":"additional","affiliation":[{"name":"Karolinska Institutet , , ,","place":["Huddinge, Stockholm, Sweden, 14152"]},{"name":"Karolinska University Hospital , , ,","place":["Stockholm, Sweden, 14186"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ojansivu","sequence":"additional","affiliation":[{"name":"Karolinska Institutet , , ,","place":["Huddinge, Stockholm, Sweden, 14152"]},{"name":"Karolinska University Hospital , , ,","place":["Stockholm, Sweden, 14186"]},{"name":"Karolinska Institutet , , ,","place":["Stockholm, Sweden, 14152"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Saher","sequence":"additional","affiliation":[{"name":"Karolinska Institutet , , ,","place":["Huddinge, Stockholm, Sweden, 14152"]},{"name":"Karolinska University Hospital , , ,","place":["Stockholm, Sweden, 14186"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bood","sequence":"additional","affiliation":[{"name":"AstraZeneca , , ,","place":["Mo\u0308lndal, Sweden, 43153"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Zain","sequence":"additional","affiliation":[{"name":"Karolinska Institutet , , ,","place":["Huddinge, Stockholm, Sweden, 14152"]},{"name":"Karolinska University Hospital , , ,","place":["Stockholm, Sweden, 14186"]},{"name":"Karolinska Institutet , , ,","place":["Stockholm, Sweden, 14152"]},{"name":"Karolinska University Hospital , , ,","place":["Stockholm, Sweden, SE-17176"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"El Andaloussi","sequence":"additional","affiliation":[{"name":"Karolinska Institutet , , ,","place":["Huddinge, Stockholm, Sweden, 14152"]},{"name":"Karolinska University Hospital , , ,","place":["Stockholm, Sweden, 14186"]},{"name":"Karolinska Institutet , , ,","place":["Stockholm, Sweden, 14152"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Honcharenko","sequence":"additional","affiliation":[{"name":"Karolinska Institutet , , ,","place":["Huddinge, Stockholm, Sweden, 14152"]},{"name":"Karolinska University Hospital , , ,","place":["Stockholm, Sweden, 14186"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"issue":"4","key":"2026073022112518400_cit1","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1261\/rna.079511.122","article-title":"Future Directions\nfor Medicinal Chemistry in the Field of Oligonucleotide Therapeutics","volume":"29","author":"Hall","year":"2023","journal-title":"RNA"},{"issue":"1","key":"2026073022112518400_cit2","doi-asserted-by":"publisher","first-page":"102440","DOI":"10.1016\/j.omtn.2024.102440","article-title":"Nucleic Acid Therapeutics:\nPast, Present, and Future","volume":"36","author":"Naeem","year":"2025","journal-title":"Molecular Therapy\nNucleic Acids"},{"issue":"1","key":"2026073022112518400_cit3","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1146\/annurev-pharmtox-010818-021050","article-title":"Therapeutic Oligonucleotides: State of the Art","volume":"59","author":"Smith","year":"2019","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"6","key":"2026073022112518400_cit4","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1093\/nar\/gkad067","article-title":"Chemistry,\nStructure and Function of Approved Oligonucleotide\nTherapeutics","volume":"51","author":"Egli","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"2026073022112518400_cit5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1089\/nat.2018.0736","article-title":"GalNAc-siRNA\nConjugates: Leading the Way for Delivery\nof RNAi Therapeutics","volume":"28","author":"Springer","year":"2018","journal-title":"Nucleic Acid Therapeutics"},{"issue":"10","key":"2026073022112518400_cit6","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in Oligonucleotide Drug\nDelivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nat. Rev. Drug Discov"},{"key":"2026073022112518400_cit7","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.jconrel.2024.04.022","article-title":"Lipid Nanoparticle-Based\nStrategies for Extrahepatic Delivery of Nucleic Acid Therapies - Challenges\nand Opportunities","volume":"370","author":"Simonsen","year":"2024","journal-title":"J. Controlled Release"},{"issue":"1","key":"2026073022112518400_cit8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41392-021-00631-2","article-title":"Recent Progress in Targeted Delivery\nVectors Based on Biomimetic\nNanoparticles","volume":"6","author":"Chen","year":"2021","journal-title":"Sig Transduct Target Ther"},{"issue":"1","key":"2026073022112518400_cit9","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1038\/s41467-025-58523-w","article-title":"Liposomal Lipid\nNanoparticles for\nExtrahepatic Delivery of mRNA","volume":"16","author":"Cheng","year":"2025","journal-title":"Nat. Commun."},{"issue":"45","key":"2026073022112518400_cit10","doi-asserted-by":"publisher","first-page":"39241","DOI":"10.1021\/acsnano.5c12871","article-title":"Virus-Inspired mRNA\nDelivery Vehicle Enabled by a Multilayered Nucleic Acid Nanocapsule","volume":"19","author":"Pal","year":"2025","journal-title":"ACS Nano"},{"issue":"13","key":"2026073022112518400_cit11","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1021\/acs.accounts.5c00126","article-title":"Nucleic\nAcid Nanocapsules as a New\nPlatform to Deliver Therapeutic Nucleic Acids for Gene Regulation","volume":"58","author":"Pal","year":"2025","journal-title":"Acc. Chem. Res."},{"issue":"18","key":"2026073022112518400_cit12","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.3390\/cells12182253","article-title":"Therapeutic Oligonucleotides: An\nOutlook on Chemical Strategies to Improve Endosomal Trafficking","volume":"12","author":"Mangla","year":"2023","journal-title":"Cells"},{"issue":"3","key":"2026073022112518400_cit13","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1093\/nar\/gky1239","article-title":"Diverse Lipid Conjugates\nfor Functional Extra-Hepatic siRNA Delivery in Vivo","volume":"47","author":"Biscans","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"2026073022112518400_cit14","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jconrel.2022.07.041","article-title":"Engineered Ionizable\nLipid siRNA Conjugates Enhance Endosomal Escape but Induce Toxicity\nin Vivo","volume":"349","author":"Biscans","year":"2022","journal-title":"J. Controlled Release"},{"issue":"3","key":"2026073022112518400_cit15","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jconrel.2013.09.013","article-title":"Factors Controlling\nthe Pharmacokinetics, Biodistribution and Intratumoral Penetration\nof Nanoparticles","volume":"172","author":"Ernsting","year":"2013","journal-title":"J. Controlled Release"},{"issue":"4","key":"2026073022112518400_cit16","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202013243","article-title":"Delivery of Oligonucleotide-based\nTherapeutics: Challenges and Opportunities","volume":"13","author":"Hammond","year":"2021","journal-title":"EMBO Molecular Medicine"},{"issue":"11","key":"2026073022112518400_cit17","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.3390\/pharmaceutics14112520","article-title":"siRNA Functionalized\nLipid Nanoparticles (LNPs) in Management of Diseases","volume":"14","author":"Kalita","year":"2022","journal-title":"Pharmaceutics"},{"issue":"4","key":"2026073022112518400_cit18","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1016\/j.ymthe.2020.12.023","article-title":"Docosanoic Acid Conjugation to siRNA\nEnables Functional and Safe Delivery to Skeletal and Cardiac Muscles","volume":"29","author":"Biscans","year":"2021","journal-title":"Molecular Therapy"},{"issue":"5","key":"2026073022112518400_cit19","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1021\/cb501028c","article-title":"siRNA Conjugates Carrying Sequentially\nAssembled Trivalent N-Acetylgalactosamine Linked Through Nucleosides\nElicit Robust Gene Silencing In Vivo in Hepatocytes","volume":"10","author":"Matsuda","year":"2015","journal-title":"ACS Chem. Biol."},{"issue":"2","key":"2026073022112518400_cit20","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1161\/CIRCRESAHA.117.311311","article-title":"RNA Therapeutics\nin Cardiovascular\nDisease","volume":"123","author":"Lucas","year":"2018","journal-title":"Circ. Res."},{"issue":"5","key":"2026073022112518400_cit21","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s40265-025-02173-1","article-title":"The Potential of RNA Therapeutics\nin Treating Cardiovascular Disease","volume":"85","author":"Mainkar","year":"2025","journal-title":"Drugs"},{"issue":"5935","key":"2026073022112518400_cit22","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1126\/science.1174381","article-title":"MicroRNA-92a Controls\nAngiogenesis and Functional Recovery of Ischemic Tissues in Mice","volume":"324","author":"Bonauer","year":"2009","journal-title":"Science"},{"issue":"1","key":"2026073022112518400_cit23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13221-015-0031-1","article-title":"Therapeutic\nManipulation of Angiogenesis\nwith miR-27b","volume":"7","author":"Veliceasa","year":"2015","journal-title":"Vascular Cell"},{"issue":"6","key":"2026073022112518400_cit24","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1161\/CIRCRESAHA.121.319478","article-title":"Targeting CaMKII-\u03949\nAmeliorates\nCardiac Ischemia\/Reperfusion Injury by Inhibiting Myocardial Inflammation","volume":"130","author":"Yao","year":"2022","journal-title":"Circ. Res."},{"issue":"16","key":"2026073022112518400_cit25","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.1073\/pnas.1613203114","article-title":"Effects of Systemic Multiexon Skipping\nwith Peptide-Conjugated Morpholinos in the Heart of a Dog Model of\nDuchenne Muscular Dystrophy","volume":"114","author":"Echigoya","year":"2017","journal-title":"Proc. Natl. Acad.\nSci. U. S. A."},{"issue":"6","key":"2026073022112518400_cit26","doi-asserted-by":"publisher","first-page":"gkaf241","DOI":"10.1093\/nar\/gkaf241","article-title":"AOC 1044 Induces Exon 44 Skipping\nand Restores Dystrophin Protein in Preclinical Models of Duchenne\nMuscular Dystrophy","volume":"53","author":"Etxaniz","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"2026073022112518400_cit27","doi-asserted-by":"publisher","first-page":"102060","DOI":"10.1016\/j.omtn.2023.102060","article-title":"Efficacy of Exon-Skipping Therapy\nfor DMD Cardiomyopathy with Mutations in Actin Binding Domain 1","volume":"34","author":"Shiba","year":"2023","journal-title":"Molecular Therapy Nucleic Acids"},{"key":"2026073022112518400_cit28","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jcis.2023.06.209","article-title":"Interacting\nCollagen and Tannic Acid Particles: Uncovering pH-Dependent Rheological\nand Thermodynamic Behaviors","volume":"650","author":"Sarker","year":"2023","journal-title":"J. Colloid Interface\nSci."},{"issue":"5","key":"2026073022112518400_cit29","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/bip.22405","article-title":"Investigation\non Interaction of Tannic Acid with Type I Collagen and Its Effect\non Thermal, Enzymatic, and Conformational Stability for Tissue Engineering\nApplications","volume":"101","author":"Velmurugan","year":"2014","journal-title":"Biopolymers"},{"issue":"24","key":"2026073022112518400_cit30","doi-asserted-by":"publisher","first-page":"6850","DOI":"10.1111\/febs.15776","article-title":"A Guide to\nthe Composition and Functions of the Extracellular\nMatrix","volume":"288","author":"Karamanos","year":"2021","journal-title":"FEBS Journal"},{"issue":"5","key":"2026073022112518400_cit31","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41551-018-0227-9","article-title":"Targeting Protein and Peptide Therapeutics\nto the Heart via Tannic Acid Modification","volume":"2","author":"Shin","year":"2018","journal-title":"Nat.\nBiomed Eng."},{"issue":"39","key":"2026073022112518400_cit32","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202305576","article-title":"Myocardial-Targeting\nTannic Cerium Nanocatalyst Attenuates Ischemia\/Reperfusion Injury","volume":"62","author":"Wang","year":"2023","journal-title":"Angew. Chem., Int. Ed."},{"issue":"6","key":"2026073022112518400_cit33","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1021\/acsabm.4c00168","article-title":"Selective Binding\nof Tannic Acid-Conjugated Lipid Nanovesicles to Proline-Rich Proteins\nEnhances Transdermal Lipophilic-Antioxidant Delivery","volume":"7","author":"Jeon","year":"2024","journal-title":"ACS Appl. Bio Mater."},{"issue":"12","key":"2026073022112518400_cit34","doi-asserted-by":"publisher","first-page":"6029","DOI":"10.1093\/nar\/gkz354","article-title":"Fatty Acid\nConjugation Enhances Potency\nof Antisense Oligonucleotides in Muscle","volume":"47","author":"Prakash","year":"2019","journal-title":"Nucleic\nAcids Res."},{"issue":"7","key":"2026073022112518400_cit35","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1039\/C9MD00018F","article-title":"Non-Covalent Albumin-Binding Ligands\nfor Extending the Circulating Half-Life of Small Biotherapeutics","volume":"10","author":"Zorzi","year":"2019","journal-title":"Medchemcomm"},{"issue":"10","key":"2026073022112518400_cit36","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/s41587-022-01334-x","article-title":"Expanding\nRNAi Therapeutics to Extrahepatic Tissues with Lipophilic Conjugates","volume":"40","author":"Brown","year":"2022","journal-title":"Nat. Biotechnol."},{"issue":"19","key":"2026073022112518400_cit37","doi-asserted-by":"publisher","first-page":"10969","DOI":"10.1093\/nar\/gkx818","article-title":"Impact of Enhanced Metabolic Stability\non Pharmacokinetics\nand Pharmacodynamics of GalNAc-siRNA Conjugates","volume":"45","author":"Nair","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"2026073022112518400_cit38","doi-asserted-by":"publisher","first-page":"102579","DOI":"10.1016\/j.omtn.2025.102579","article-title":"Albumin-Binding Dendritic\nsiRNA Improves Delivery and\nEfficacy to Solid Tumors in a Melanoma Model","volume":"36","author":"Fakih","year":"2025","journal-title":"Molecular Therapy Nucleic Acids"},{"issue":"5","key":"2026073022112518400_cit39","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1161\/HYPERTENSIONAHA.115.07012","article-title":"On the\nOrigin of Urinary Renin","volume":"67","author":"Roksnoer","year":"2016","journal-title":"Hypertension"},{"issue":"3","key":"2026073022112518400_cit40","doi-asserted-by":"publisher","first-page":"201","DOI":"10.7150\/thno.5743","article-title":"Optimized siRNA-PEG Conjugates for\nExtended Blood Circulation and Reduced Urine Excretion in Mice","volume":"3","author":"Iversen","year":"2013","journal-title":"Theranostics"},{"key":"2026073022112518400_cit41","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.omtn.2022.06.005","article-title":"PK-Modifying Anchors Significantly Alter Clearance\nKinetics, Tissue Distribution, and Efficacy of Therapeutics siRNAs","volume":"29","author":"Godinho","year":"2022","journal-title":"Mol. Ther Nucleic Acids"},{"issue":"3","key":"2026073022112518400_cit42","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1093\/nar\/gky1232","article-title":"Hydrophobicity\nDrives the Systemic Distribution of Lipid-Conjugated siRNAs via Lipid\nTransport Pathways","volume":"47","author":"Osborn","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"2026073022112518400_cit43","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.3390\/molecules26092429","article-title":"Self-Crosslinked\nEllipsoidal Poly(Tannic Acid) Particles for Bio-Medical Applications","volume":"26","author":"Sahiner","year":"2021","journal-title":"Molecules"},{"key":"2026073022112518400_cit44","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.msec.2015.01.076","article-title":"Single Step Natural\nPoly(Tannic Acid)\nParticle Preparation as Multitalented Biomaterial","volume":"49","author":"Sahiner","year":"2015","journal-title":"Materials Science and Engineering: C"},{"issue":"12","key":"2026073022112518400_cit45","doi-asserted-by":"publisher","first-page":"4278","DOI":"10.1021\/jacs.6b13359","article-title":"Cross-Linked Micellar\nSpherical Nucleic\nAcids from Thermoresponsive Templates","volume":"139","author":"Banga","year":"2017","journal-title":"J. Am.\nChem. Soc."},{"issue":"6","key":"2026073022112518400_cit46","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1021\/acs.accounts.5c00775","article-title":"Spherical Nucleic Acids: Turning\nSynthetic Advances and Fundamental Discovery into Translational Breakthroughs\nin Chemistry, Materials Development, Biology, and Medicine","volume":"59","author":"Forsyth","year":"2026","journal-title":"Acc. Chem. Res."}],"container-title":["Bioconjugate Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.bioconjchem.6c00122","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/bcches\/article-pdf\/37\/6\/1121\/66265229\/acs.bioconjchem.6c00122.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/bcches\/article-pdf\/37\/6\/1121\/66265229\/acs.bioconjchem.6c00122.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:11:35Z","timestamp":1785463895000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/bcches\/article\/37\/6\/1121\/5233098\/Investigating-the-In-Vivo-Performance-of-Tannic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,5,27]]},"published-print":{"date-parts":[[2026,6,17]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.bioconjchem.6c00122","relation":{},"ISSN":["1043-1802","1520-4812"],"issn-type":[{"value":"1043-1802","type":"print"},{"value":"1520-4812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]}}}